%D8%A5%D8%B3%D9%8A%D8%AA%D8%A7%D9%84%D9%88%D8%A8%D8%B1%D8%A7%D9%85Escitalopram%D8%A7%D8%B3%DA%A9%D9%84%DB%8C%D8%AA%D9%88%D9%BE%D8%A7%D9%85Category:EscitalopramEscitalopramEscitalopramEscitalopram%CE%95%CF%83%CE%BA%CE%B9%CF%84%CE%B1%CE%BB%CE%BF%CF%80%CF%81%CE%AC%CE%BC%CE%B7EscitalopramEscitalopram%D8%A7%D8%B3%E2%80%8C%D8%B3%DB%8C%D8%AA%D8%A7%D9%84%D9%88%D9%BE%D8%B1%D8%A7%D9%85EssitalopraamiEscitalopram%D7%90%D7%A1%D7%A6%D7%99%D7%98%D7%9C%D7%95%D7%A4%D7%A8%D7%9DEszcitalopramEscitalopram%E3%82%A8%E3%82%B9%E3%82%B7%E3%82%BF%E3%83%AD%E3%83%97%E3%83%A9%E3%83%A0%EC%97%90%EC%8A%A4%EC%8B%9C%ED%83%88%EB%A1%9C%ED%94%84%EB%9E%8CEscitalopram%E0%AC%8F%E0%AC%B8%E0%AC%BF%E0%AC%9F%E0%AC%BE%E0%AC%B2%E0%AD%8B%E0%AC%AA%E0%AD%8D%E0%AC%B0%E0%AC%BE%E0%AC%AEEscitalopramEscitalopram%D0%AD%D1%81%D1%86%D0%B8%D1%82%D0%B0%D0%BB%D0%BE%D0%BF%D1%80%D0%B0%D0%BCEscitalopramEscitalopramEscitalopramEscitalopramEscitalopramEssitalopram%D0%95%D1%81%D1%86%D0%B8%D1%82%D0%B0%D0%BB%D0%BE%D0%BF%D1%80%D0%B0%D0%BCQ423757%D7%A2%D7%A1%D7%A6%D7%99%D7%98%D7%90%D7%9C%D7%90%D7%A4%D7%A8%D7%90%D7%9D%E8%89%BE%E5%8F%B8%E8%A5%BF%E9%85%9E%E6%99%AE%E5%85%B0
about
P3781
probucolclarithromycinpimozideazithromycindroperidol(RS)-methadoneerythromycinhaloperidoldofetilideibutilidechlorpromazineanagrelidedronedarone(RS)-citalopramondansetronamiodaronequinidinesotalolcocainepentamidineprocainamideterfenadinesevofluraneflecainidesulpiridechloroquineastemizoledomperidonemoxifloxacindisopyramidecisapridebepridilthioridazinemesoridazinearsenic trioxideHalofantrinesparfloxacin
P769
Neonatal Toxicity From Escitalopram Use In Utero: A Case Report.A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.Escitalopram: a pharmacoeconomic review of its use in depression.Escitalopram is a weak inhibitor of the CYP2D6-catalyzed O-demethylation of (+)-tramadol but does not reduce the hypoalgesic effect in experimental pain.Escitalopram: a review of its use in the management of major depressive disorder.Escitalopram: a review of its use in the management of anxiety disorders.Clinical pharmacology review of escitalopram for the treatment of depression.Escitalopram treatment of depression in human immunodeficiency virus/acquired immunodeficiency syndrome: a randomized, double-blind, placebo-controlled study.A pharmacoeconomic evaluation of escitalopram, a new selective serotonin reuptake inhibitor. Comparison of cost-effectiveness between escitalopram, citalopram, fluoxetine, and venlafaxine for the treatment of depression in Norway.R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model.Therapeutic drug monitoring of 13 antidepressant and five neuroleptic drugs in serum with liquid chromatography-electrospray ionization mass spectrometry.Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria.Escitalopram-induced Parkinsonism.[Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis.Debunking the placebo effect in depression: the effect of patient and investigator expectation on escitalopram efficacy.Effects of diverse psychopharmacological substances on the activity of brain prolyl oligopeptidase.Escitalopram in the treatment of anxiety symptoms associated with depressionPharmacological and Neuromodulatory Treatments for Panic Disorder: Clinical Trials from 2010 to 2018Fecal Microbiota Analysis in Patients Going through a Depressive Episode during Treatment in a Psychiatric Hospital SettingRepeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in ratsPharmacotherapy for the treatment of depression in patients with alzheimer's disease: a treatment-resistant depressive disorderInfluence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
P921
Q154430-CB424DDD-695A-4314-B3FD-31C9E61D653AQ178190-6ADAFF04-3FCD-48FD-95DE-6742C1F55E7CQ19000444-9F11C897-3E85-48C2-AF1A-7391456F3EA2Q202387-8C29CAC7-97D2-48D1-A654-711D724C0E66Q3184856-68C1BB35-3385-4416-B16A-B104B35D1B34Q544006-9DB7ECB1-D58F-4CA7-A049-90CE0C3D454BQ845224-D8D94048-1074-42A6-A810-9509AB9C0867
P2176
Q10354103-940AA66E-B471-4C9A-BF2E-F036103EC281Q118551-30AF8E5F-86A3-46CF-B7E4-DE15B2914E7DQ144085-1EC1E008-A7B3-4C3E-A510-C69876181E3FQ165399-4D19397D-4423-4E95-8D9E-296DD99B95B0Q174259-00794C74-6EB3-43F7-927D-3D7DDB1F4979Q179996-3C9020C6-106A-4427-9330-3C02FC3F4800Q213511-11750CAE-0D6F-4137-BF8E-9FB4F2449C9FQ251347-E933D17D-0FD4-4231-A1DB-D3734F1D1420Q3712521-251306CF-383F-41A5-AE2C-D11646FDA369Q3791612-B9369084-3F5D-48A4-AF38-29FDD0AD68CEQ407972-B287EB80-77BF-4214-A949-747F924B5E8DQ408163-21ED3C4C-1433-47CF-80BF-9F41B0A72D75Q408637-96F9E4F9-0522-43EB-876C-109DC44D0406Q409672-E95A0509-CEFC-407D-A510-270309477E9EQ410011-14356F48-5A4D-47FD-9DD3-9D922974DFC9Q410061-E8F26600-C2EC-4885-AC67-7D0F5B9560CEQ412496-0FE379DD-3341-4BE3-B209-6A769762C25AQ413591-4D309A93-33AF-4E5D-85CC-803E0FA320A5Q41576-E7AA3FFA-9C7C-458A-BB8C-496ECBE255BAQ416206-F82D53F3-04FE-43C4-AA1C-5EDCC4FF1416Q417597-D90AF8B9-FAAF-47B1-8370-784762144C1EQ417909-8828F684-E78A-4A97-B147-26BDEE0F33A4Q419394-C6B5AF4A-7F64-4D46-A1BF-91B3D8DEF848Q421381-A0D4C8EF-25E2-4D57-9C46-42037F2F48CCQ422418-8A238FE9-3609-49ED-8BCB-580852F20A57Q422438-6030C7D8-DB82-4CD3-91E9-5BBEDDD0667DQ423437-1906D859-EEB2-4B24-AF0E-F91D97DFE759Q424238-BFFB663F-E89D-495D-BB7C-D5C8A14EC628Q424940-AB29B07C-2FA1-4D14-8E4B-662B6DDFA6BBQ425120-388EBD1F-63B2-4B51-B454-22CB1CD013B5Q425295-AD4F24E0-7FFC-47A8-A76B-850D7AFD2C33Q4890934-7E80A98B-28BE-428D-8ABE-AE6A9CCA3D07Q58375-8AC2FAF1-E151-4003-98D1-B123EB01B882Q6821618-505546A4-472C-4766-BB84-6959F486D771Q7739-C62F5C56-77FD-493E-BD6B-D7C343261A8AQ947595-71F84254-B619-4AF7-AB91-94A81B1386C8Q976559-92DAC9B4-C8F5-4DCA-8212-94D5E8892DAF
P769
description
antidepressant of the selective serotonin reuptake inhibitor (SSRI) class
@en
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
ESCITALOPRAM
@ro
Escitalopram
@ast
Escitalopram
@cs
Escitalopram
@de
Escitalopram
@es
Escitalopram
@it
Escitalopram
@nl
Escitalopram
@sh
Escitalopram
@sl
Escitalopram
@sr-el
type
label
ESCITALOPRAM
@ro
Escitalopram
@ast
Escitalopram
@cs
Escitalopram
@de
Escitalopram
@es
Escitalopram
@it
Escitalopram
@nl
Escitalopram
@sh
Escitalopram
@sl
Escitalopram
@sr-el
altLabel
(+)-Citalopram
@en
(+)-citalopram
@cy
(+)-citalopram
@en
(S)-Citalopram
@en
(S)-citalopram
@cy
(S)-citalopram
@en
(S)-citalopram
@pl
(S)-cytalopram
@pl
128196-01-0
@fr
Anxiset E
@cs
prefLabel
ESCITALOPRAM
@ro
Escitalopram
@ast
Escitalopram
@cs
Escitalopram
@de
Escitalopram
@es
Escitalopram
@it
Escitalopram
@nl
Escitalopram
@sh
Escitalopram
@sl
Escitalopram
@sr-el